EW HEALTHCARE PARTNERS
EW HEALTHCARE PARTNERS is a Series C+ fund in the US and Europe writing $5M–$100M checks into Healthcare, pharmaceuticals, medical-devices and healthcare-services.
- Stages
- Series C+
- Sectors
- Healthcare, pharmaceuticals, medical-devices, healthcare-services
- Check size
- $5M–$100M
- Invests in
- US-wide, Europe
- Founded
- 1985
- Assets under management
- $2.05B
- Website
- ewhealthcare.com
Thesis
EW Healthcare Partners is a private equity firm focused on healthcare investments in the United States and Europe. The firm targets commercial-stage companies with revenues between $20 million and $200 million, demonstrating the potential for approximately 20% annual revenue growth. EW Healthcare Partners seeks to lead fast-growing, revenue-generating healthcare companies, particularly those with patented, proprietary products in pharmaceuticals, medical devices, healthcare services, and technology-enabled services. The firm manages approximately $2.05 billion in assets as of December 31, 2024, and has raised close to $4 billion since its inception. They invest through private equity and venture capital funds, as well as co-investment vehicles.
Common questions
Does EW HEALTHCARE PARTNERS invest at the Series C+ stage?
Yes. EW HEALTHCARE PARTNERS lists Series C+ among the stages it invests in.
What check size does EW HEALTHCARE PARTNERS write?
EW HEALTHCARE PARTNERS writes $5M–$100M checks.
Where does EW HEALTHCARE PARTNERS invest?
EW HEALTHCARE PARTNERS invests in the US and Europe.